1094601-61-2 Usage
Chemical compound
A substance formed from the combination of two or more elements in a fixed proportion.
Piperazine derivative
A chemical compound derived from the piperazine ring structure.
Benzyl group
A phenylmethyl group (C6H5CH2-) attached to the piperazine ring.
Methyl group
A CH3 group attached to the piperazine ring.
Potential applications
Uses in the pharmaceutical and chemical industries.
Building block
Used in the synthesis of various drugs and bioactive compounds.
Versatile intermediate
Capable of being used in the production of diverse chemical compounds due to its unique structure and functional groups.
Pharmacological properties
Studied for its potential effects on the body, such as anti-inflammatory and analgesic properties.
Anti-inflammatory
Capable of reducing inflammation in the body.
Analgesic
Capable of relieving pain.
Research and development
A valuable compound for further study and development in the pharmaceutical and chemical industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1094601-61-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,9,4,6,0 and 1 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1094601-61:
(9*1)+(8*0)+(7*9)+(6*4)+(5*6)+(4*0)+(3*1)+(2*6)+(1*1)=142
142 % 10 = 2
So 1094601-61-2 is a valid CAS Registry Number.
1094601-61-2Relevant articles and documents
PIPERAZINE UREA DERIVATIVES AS MELANOCORTIN-4 RECEPTOR AGONISTS
-
Page 78-79, (2010/11/30)
Certain novel piperazine urea derivatives are agonists of the human melanocortin-4 receptor (MC-4R) and, in particular, are receptor-subtype selective agonists of MC-4R. They are useful for the treatment, control, or prevention of diseases and disorders r
Asymmetric Synthesis of 2,6-Methylated Piperazines
Mickelson, John W.,Belonga, Kenneth L.,Jacobsen, Jon E.
, p. 4177 - 4183 (2007/10/02)
The complete series of enantiopure 2,6-methylated piperazines was synthesized utilizing two alternative reactions in the key bond-forming step.The dimethyl enantiomers, (2R,6R)- and (2S,6S)-2,6-dimethylpiperazine (1, 2), were prepared using either a diastereoselective triflate alkylation or a novel intermolecular Mitsunobu reaction to set the required stereochemistry.The monomethyl derivatives, (R)- and (S)-tert-butyl 2-methyl-1-piperazinecarboxylate (3, 4) were also synthesized employing the Mitsunobu cyclization strategy while the trimethyl compounds, (R)- and (S)-2,2,6- trimethylpiperazine (5, 6) were prepared using an enantiospecific triflate alkylation as the principal reaction.These methods represent efficient, general strategies for preparing a variety of 2,6-methylated piperazines for which the absolute stereochemistry can be readily controlled.
